Reximed®

Methotrexate

Product Information

  • Proprietary Name: Reximed®
  • Generic Name: Methotrexate
  • Dosage Form: Vial
  • Strengths: 1000 mg/10 ml
  • Indications: Acute Lymphocytic Leukemia (ALL), Non-Hodgkin’s Lymphomas, Osteogenic Sarcoma, Breast Cancer, Head and Neck Cancer, Choriocarcinoma, Trophoblastic, Advanced Cancer of Urinary Bladder

Oncology

Reximed®

Methotrexate is indicated for the treatment of acute lymphocytic leukemia (ALL), non-hodgkin’s lymphomas, osteogenic sarcoma, breast cancer, head and neck cancer, choriocarcinoma, trophoblastic, and advanced cancer of urinary bladder.

Ready to get started?

Curious about a specific position? Sign up for it.
© NanoAlvand. All rights reserved. Powered by ِDGN.